Clinical Trial Update: VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK [Phase 4]

View source ↗

Summary

Phase 4 open-label study assessing how ketoconazole or esomeprazole influence the pharmacokinetics of pazopanib in cancer patients; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Ketoconazole (Ketoconazole)
• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 4 | Status: COMPLETED | Results posted: 2012-04-24